Page last updated: 2024-08-25

methotrexate and Death, Sudden

methotrexate has been researched along with Death, Sudden in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (40.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ambrosetti, A; Balzarotti, M; Binder, M; Cavalli, F; Cwynarski, K; Deckert, M; Fabbri, A; Ferrari, A; Ferreri, AJ; Finke, J; Fox, CP; Gørløv, JS; Hemmaway, C; Hertenstein, B; Hess, G; Illerhaus, G; Johnson, P; Keller, U; Krause, SW; Levis, A; Linton, KM; Panse, J; Pisani, F; Politi, LS; Ponzoni, M; Pukrop, T; Pulczynski, E; Reni, M; Rosée, PL; Roth, A; Rudà, R; Schmoll, HJ; Schorb, E; Stilgenbauer, S; Torri, V; Tucci, A; Zucca, E	1
Grove, ML	1
Barnett, MJ; Phillips, GL; Shore, T	1
Arseneau, JC; Canellos, GP; DeVita, VT; Sherins, RJ	1
Kaita, T; Kawamoto, K; Kimura, T; Okada, H; Otani, T	1

Reviews

1 review(s) available for methotrexate and Death, Sudden

Article	Year
Recently recognized complications of cancer chemotherapy. Annals of the New York Academy of Sciences, 1974, Volume: 230 Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Death, Sudden; Drug Therapy, Combination; Hodgkin Disease; Humans; Hyperkalemia; Infertility, Male; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Neoplasms; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Spermatogenesis; Vincristine	1974

Article

Year

Recently recognized complications of cancer chemotherapy.

Annals of the New York Academy of Sciences, 1974, Volume: 230

Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Death, Sudden; Drug Therapy, Combination; Hodgkin Disease; Humans; Hyperkalemia; Infertility, Male; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Neoplasms; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Spermatogenesis; Vincristine

1974

Trials

1 trial(s) available for methotrexate and Death, Sudden

Article	Year
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. The Lancet. Haematology, 2016, Volume: 3, Issue:5 Topics: Acute Kidney Injury; Anemia; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Comparative Effectiveness Research; Cytarabine; Death, Sudden; Denmark; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Gastrointestinal Diseases; Germany; Heart Injuries; Hematopoietic Stem Cell Transplantation; Humans; Hyperglycemia; Induction Chemotherapy; Infections; Intraocular Lymphoma; Italy; Kaplan-Meier Estimate; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Mucositis; Neurotoxicity Syndromes; Neutropenia; Optic Nerve Neoplasms; Poisoning; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Stroke; Switzerland; Thiotepa; Thrombocytopenia; Thrombosis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; United Kingdom	2016

Article

Year

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.

The Lancet. Haematology, 2016, Volume: 3, Issue:5

Topics: Acute Kidney Injury; Anemia; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Comparative Effectiveness Research; Cytarabine; Death, Sudden; Denmark; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Gastrointestinal Diseases; Germany; Heart Injuries; Hematopoietic Stem Cell Transplantation; Humans; Hyperglycemia; Induction Chemotherapy; Infections; Intraocular Lymphoma; Italy; Kaplan-Meier Estimate; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Mucositis; Neurotoxicity Syndromes; Neutropenia; Optic Nerve Neoplasms; Poisoning; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Stroke; Switzerland; Thiotepa; Thrombocytopenia; Thrombosis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; United Kingdom

2016

Other Studies

3 other study(ies) available for methotrexate and Death, Sudden

Article	Year
Methotrexate and bone marrow suppression: drug errors may be implicated in death. BMJ (Clinical research ed.), 2003, May-24, Volume: 326, Issue:7399 Topics: Antirheumatic Agents; Death, Sudden; Drug Administration Schedule; Humans; Medication Errors; Methotrexate; Neutropenia	2003
Sudden neurologic death after intrathecal methotrexate. Medical and pediatric oncology, 1990, Volume: 18, Issue:2 Topics: Adult; Brain Death; Brain Edema; Death, Sudden; Humans; Injections, Spinal; Leukemia-Lymphoma, Adult T-Cell; Leukoencephalopathy, Progressive Multifocal; Male; Meningeal Neoplasms; Methotrexate	1990
[Case of acute fatal leukemia in a child, complicated by chickenpox]. Nihon rinsho. Japanese journal of clinical medicine, 1968, Volume: 26, Issue:9 Topics: Adrenal Cortex Hormones; Bone Marrow Examination; Chickenpox; Child; Death, Sudden; Female; Humans; Leukemia, Lymphoid; Methotrexate	1968